{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T05:40:13Z","timestamp":1785649213292,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jad.2023.12.062","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T02:41:27Z","timestamp":1703817687000},"page":"200-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Neuropsychiatric symptoms in Alzheimer's continuum and their association with plasma biomarkers"],"prefix":"10.1016","volume":"348","author":[{"given":"Lin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2023.12.062_bb0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000110738","article-title":"Neuropsychiatric syndromes in dementia. Results from the European Alzheimer disease consortium: part I","volume":"24","author":"Aalten","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jad.2023.12.062_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-021-00942-0","article-title":"The accuracy and robustness of plasma biomarker models for amyloid PET positivity","volume":"14","author":"Benedet","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jad.2023.12.062_bb0015","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s43587-023-00471-5","article-title":"A two-step workflow based on plasma p-tau217 to screen for amyloid \u03b2 positivity with further confirmatory testing only in uncertain cases","volume":"3","author":"Brum","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.jad.2023.12.062_bb0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2023.12.062_bb0025","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/alz.12447","article-title":"Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer\u2019s disease","volume":"18","author":"Chatterjee","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jad.2023.12.062_bb0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-021-00949-7","article-title":"Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer\u2019s disease","volume":"14","author":"Creese","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jad.2023.12.062_bb0035","doi-asserted-by":"crossref","DOI":"10.14283\/jpad.2023.49","article-title":"Chinese preclinical Alzheimer\u2019s disease study (C-PAS): design and challenge from PET acceptance","author":"Cui","year":"2023","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.jad.2023.12.062_bb0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jpsychires.2012.12.008","article-title":"Plasma amyloid \u03b2, depression, and dementia in community-dwelling elderly","volume":"47","author":"Direk","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2023.12.062_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-150128","article-title":"Subtle cognitive decline and biomarker staging in preclinical Alzheimer\u2019s disease","volume":"47","author":"Edmonds","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jad.2023.12.062_bb0050","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/alz.12549","article-title":"Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer\u2019s disease and frontotemporal disorders in clinical settings","volume":"18","author":"Eratne","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jad.2023.12.062_bb0055","doi-asserted-by":"crossref","first-page":"e683","DOI":"10.1212\/WNL.0000000000201517","article-title":"Plasma phosphorylated tau at threonine 181 and neuropsychiatric symptoms in preclinical and prodromal Alzheimer disease","volume":"100","author":"Ghahremani","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2023.12.062_bb0060","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","article-title":"Plasma neurofilament light chain as a biomarker of Alzheimer\u2019s disease in subjective cognitive decline and mild cognitive impairment","volume":"269","author":"Giacomucci","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.jad.2023.12.062_bb0065","first-page":"81","article-title":"Boston naming test in Chinese elderly, patient with mild cognitive impairment and Alzheimer\u2019s dementia","volume":"20","author":"Guo","year":"1991","journal-title":"Chin. Ment. Health J."},{"key":"10.1016\/j.jad.2023.12.062_bb0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13195-023-01174-0","article-title":"The dynamics of plasma biomarkers across the Alzheimer\u2019s continuum","volume":"15","author":"Guo","year":"2023","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jad.2023.12.062_bb0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.jad.2023.12.062_bb0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2023.12.062_bb0085","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3233\/JAD-160979","article-title":"The mild behavioral impairment checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations","volume":"56","author":"Ismail","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jad.2023.12.062_bb0090","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement, \u65e0"},{"key":"10.1016\/j.jad.2023.12.062_bb0095","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement, \u65e0"},{"key":"10.1016\/j.jad.2023.12.062_bb0100","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41582-022-00665-2","article-title":"Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility","volume":"18","author":"Karikari","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jad.2023.12.062_bb0105","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0895-4356(88)90034-0","article-title":"A Chinese version of the mini-mental state examination; impact of illiteracy in a Shanghai dementia survey","volume":"41","author":"Katzman","year":"1988","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2023.12.062_bb0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1176\/jnp.12.2.233","article-title":"Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory","volume":"12","author":"Kaufer","year":"2000","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2023.12.062_bb0115","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1148\/rg.2018180160","article-title":"Signs and artifacts in amyloid PET","volume":"38","author":"Lundeen","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.jad.2023.12.062_bb0120","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jad.2023.12.062_bb0125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jad.2023.12.062_bb0130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/08919887211016068","article-title":"Plasma \u03b2-amyloid in mild behavioural impairment-neuropsychiatric symptoms on the Alzheimer\u2019s continuum","volume":"35","author":"Miao","year":"2022","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.jad.2023.12.062_bb0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jad.2023.12.062_bb0140","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3233\/JAD-200011","article-title":"Plasma neurofilament light: a marker of neurodegeneration in mild behavioral impairment","volume":"76","author":"Naude","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jad.2023.12.062_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40035-021-00236-3","article-title":"Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer\u2019s disease and cognitively unimpaired individuals","volume":"10","author":"Ng","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jad.2023.12.062_bb0150","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","article-title":"Amyloid \u03b2 concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis","volume":"13","author":"Ovod","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jad.2023.12.062_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.832700","article-title":"Non-linear character of plasma amyloid beta over the course of cognitive decline in Alzheimer\u2019s continuum","volume":"14","author":"Pan","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jad.2023.12.062_bb0160","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.2014.14040480","article-title":"Neuropsychiatric symptoms as predictors of progression to severe Alzheimer\u2019s dementia and death: the Cache County dementia progression study","volume":"172","author":"Peters","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.12.062_bb0165","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/gps.4339","article-title":"Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer\u2019s disease","volume":"31","author":"Qiu","year":"2016","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2023.12.062_bb0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuroscience.2023.01.004","article-title":"Brain functional alterations and association with cognition in people with preclinical subjective cognitive decline and objective subtle cognitive difficulties","volume":"513","author":"Ren","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.jad.2023.12.062_bb0175","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Rm","year":"2016","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jad.2023.12.062_bb0180","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2023.12.062_bb0185","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archpsyc.65.5.542","article-title":"Amyloid-associated depression: a prodromal depression of Alzheimer disease?","volume":"65","author":"Sun","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2023.12.062_bb0190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11920-018-0978-8","article-title":"Diagnosis and Management of neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"20","author":"Wolinsky","year":"2018","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2023.12.062_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051157","article-title":"Short-term delayed recall of auditory verbal learning test is equivalent to long-term delayed recall for identifying amnestic mild cognitive impairment","volume":"7","author":"Zhao","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jad.2023.12.062_bb0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12264-013-1301-7","article-title":"Clustering and switching during a semantic verbal fluency test contribute to differential diagnosis of cognitive impairment","volume":"29","author":"Zhao","year":"2013","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jad.2023.12.062_bb0205","article-title":"The shape trail test: application of a new variant of the trail making test","volume":"8","author":"Zhao","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jad.2023.12.062_bb0210","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jad.2015.09.069","article-title":"The prevalence of neuropsychiatric symptoms in Alzheimer\u2019s disease: systematic review and meta-analysis","volume":"190","author":"Zhao","year":"2016","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272301529X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272301529X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:18:00Z","timestamp":1759033080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503272301529X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":42,"alternative-id":["S016503272301529X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2023.12.062","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropsychiatric symptoms in Alzheimer's continuum and their association with plasma biomarkers","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2023.12.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}